Is C-reactive protein an additional, surrogate end-point for statin treatment?
article
Chemicals/CAS: Anticholesteremic Agents; atorvastatin, 110862-48-1; Biological Markers; C-Reactive Protein, 9007-41-4; Cholesterol, HDL; Cholesterol, LDL; Heptanoic Acids; Pyrroles; Triglycerides
Topics
TNO Identifier
236537
ISSN
0195668X
Source
European Heart Journal, 23(10), pp. 761-764.
Pages
761-764
Files
To receive the publication files, please send an e-mail request to TNO Repository.